# Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

> **NCT00965250** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 49 (actual)

## Conditions studied

- Thymoma
- Thymic Carcinoma
- Thymic Carcinoid
- Thymic Neuroendocrine Tumors

## Interventions

- **DRUG:** IMC-12

## Key facts

- **NCT ID:** NCT00965250
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-03
- **Final completion:** 2016-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2016-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965250, "Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy". Retrieved via MORVS 2026-10-06 from https://api.morvs.ai/clinical/NCT00965250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*